AVPN & Bayer Foundation unveil US$ 5 million “Climate x Health: Lighthouse for Asia” Fund to protect community health: Our Bureau, Bengaluru Wednesday, November 20, 2024, 11:1 ...
Malvern, Pennsylvania Wednesday, November 20, 2024, 11:00 Hrs [IST] ...
Telangana govt states it emerges as global life sciences hub with over Rs. 36,000 crore in investments, creating 51,000 jobs: Our Bureau, Bengaluru Wednesday, November 20, 2024, 1 ...
GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...
The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, the region’s premier international pharmaceutical trade platform, will take place at the BBCFEC, Purbachal, Dhaka from February 12-14, 2025. This ...
DGTR issues interested parties list for anti-dumping investigation on PTFE imports from China & Russia: Shardul Nautiyal, Mumbai Wednesday, November 20, 2024, 08:00 Hrs [IST] The ...
Increasing prevalence of AMR leads to more complicated infections: Nandita Vijayasimha, Bengaluru Wednesday, November 20, 2024, 08:00 Hrs [IST] The increasing prevalence of antimi ...
The Kerala drug controller’s inclusion in the committee is quite understandable as it was the then Kerala drug controller, Dr. Revi Menon, who started a novel project in 2018 to tackle the unsafe ...
As part of celebrating the National Pharmacy Week (NPW), the Kerala state branch of the Indian Pharmaceutical Association (IPA) is organizing five zonal programmes across the state, from November 21 ...
Following a pivotal virtual meeting aimed at exploring business opportunities in the pharmaceutical sector, the High Commission of India in Ulaanbaatar and the Pharmaceuticals Export Promotion Council ...
NPPA revises ceiling price of six formulations based on DoP's review order: Gireesh Babu, New Delhi Wednesday, November 20, 2024, 08:00 Hrs [IST] The National Pharmaceutical Prici ...
Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...